According to our finding of NP, AKT1, CASP3, EGFR, and IGF1 played critical roles in the treatment of SLE with IGU. These target proteins are involved in oxidative stress, inflammation, angiogenesis, and immunomodulator. The gene discussed is AKT1; the disease is systemic lupus erythematosus.